Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 May;93(3):165-175.
doi: 10.1097/MD.0000000000000030.

Rosai-Dorfman disease of the central nervous system: report of 6 cases and review of the literature

Affiliations
Free PMC article
Review

Rosai-Dorfman disease of the central nervous system: report of 6 cases and review of the literature

Jose D Sandoval-Sus et al. Medicine (Baltimore). 2014 May.
Free PMC article

Abstract

Rosai-Dorfman disease (RDD), also known as sinus histiocytosis with massive lymphadenopathy (SHML), is an uncommon benign idiopathic lymphoproliferative disorder. The histologic hallmark of RDD is the finding of emperipolesis displayed by lesional histiocytes. While RDD most commonly affects lymph nodes, extranodal involvement of multiple organs has been reported, including the central nervous system (CNS). However, CNS involvement in RDD is rare and is not well characterized. As a result, therapeutic approaches to CNS involvement in RDD are not well established. Herein we report 6 cases of RDD with isolated CNS involvement and review the literature on RDD with CNS involvement. One of the presented cases exhibited intramedullary involvement of the spinal cord--a very rare form of RDD with CNS involvement.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Neuroimaging findings in Cases 1 and 2. A, Sagittal postcontrast T1-weighted MRI showing a lobulated enhancing extraaxial mass (arrow) in the retroclival region with secondary mass effect over the ventral aspect of the pons and medulla oblongata in Case 1. B, Axial postcontrast T1-weighted MRI showing the same lobulated mass. C, Sagittal postcontrast T1-weighted MRI demonstrates an extraaxial homogeneously enhancing mass in the posterior fossa extending inferiorly to the foramen magnum and into the cervical canal with associated mass effect on the dorsal aspect of the cervicomedullary junction and cervical spinal cord in Case 1. D, Axial postcontrast T1-weighted MRI showing an elongated homogeneous enhancing extraaxial mass (arrow) in the left cerebellopontine angle with mild mass effect over the left aspect of the pons and anterior left cerebellum in Case 2. E, Axial postcontrast T1-weighted MRI demonstrating nodular enhancement along the dura and tentorium (arrows) in Case 2.
FIGURE 2
FIGURE 2
Pathologic findings in RDD involving the CNS. All cases in this series had similar morphologic features, and representative images are shown. A, B, and C, Biopsies contained an abnormal vaguely nodular polymorphous lymphohistiocytic infiltrate (hematoxylin and eosin; 4× magnification in A) composed of abundant loosely cohesive large histiocytes admixed with numerous small mature lymphocytes and plasma cells (hematoxylin and eosin; 10× magnification in B and C). D and E, Within the aggregates of histiocytes, the diagnostic feature of emperipolesis was identified in all cases (hematoxylin and eosin; 50× magnification). F, The cells are positive for S-100 protein by immunohistochemistry (hematoxylin and eosin; 20× magnification).
FIGURE 3
FIGURE 3
Neuroimaging findings in Cases 3 and 4. A, Sagittal postcontrast T2-weighted MRI showing an abnormal hyperintense intramedullary lesion throughout the cervical cord at C5-C6 (arrow) in Case 3. B, Axial postcontrast T1-weighted MRI demonstrating an extraaxial homogeneously enhancing mass (arrow) in the right prepontine cistern with mass effect on the ventral aspect of the pons in Case 3. C and D, Sagittal postcontrast T1-weighted MRI demonstrates multiple areas of nodular enhancement along the ventral aspect of the cervicomedullary junction consistent with dura-based lesion in Case 4.

Similar articles

Cited by

References

    1. Adeleye AO, Amir G, Fraifeld S, Shoshan Y, Umansky F, Spektor S. Diagnosis and management of Rosai-Dorfman disease involving the central nervous system. Neurol Res. 2010;32:572–578. - PubMed
    1. Alqanatish JT, Houghton K, Bond M, Senger C, Tucker LB. Rituximab treatment in a child with Rosai-Dorfman disease and systemic lupus erythematosus. J Rheumatol. 2010;37:1783–1784. - PubMed
    1. Amagasa M, Yuda F, Kojima H, Noshita N, Sato S. Natural course of lymphocytic infundibuloneurohypophysitis. Clin Neuropathol. 2001; 20: 229– 232. - PubMed
    1. Andriko JA, Morrison A, Colegial CH, Davis BJ, Jones RV. Rosai-Dorfman disease isolated to the central nervous system: a report of 11 cases. Mod Pathol. 2001; 14: 172– 178. - PubMed
    1. Antuna Ramos A, Alvarez Vega MA, Alles JV, Antuna Garcia MJ, Meilan Martinez A. Multiple involvement of the central nervous system in Rosai-Dorfman disease. Pediatr Neurol. 2012; 46: 54– 56. - PubMed